Filters
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Progressive Renal Disease Panel Invitae United States | 310 | 195 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
Johns Hopkins Genomics DNA Diagnostic Laboratory Johns Hopkins University, School of Medicine United States | 525 | 338 |
|
Bartter syndrome and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 9 | 9 |
|
Bartter syndrome and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 9 | 9 |
|
Bartter syndrome and related disorders NGS panel HNL Genomics Connective Tissue Gene Tests United States | 9 | 9 |
|
Nephrolithiasis and related disorders Deletion / Duplication panel HNL Genomics Connective Tissue Gene Tests United States | 32 | 31 |
|
Nephrolithiasis and related disorders Comprehensive panel HNL Genomics Connective Tissue Gene Tests United States | 32 | 31 |
|
Nephrolithiasis and related disorders NGS panel HNL Genomics Connective Tissue Gene Tests United States | 32 | 31 |
|
Nephrolithiasis and Nephrocalcinosis Panel PreventionGenetics, part of Exact Sciences United States | 33 | 30 |
|
Bartter Syndrome Type 2 via the KCNJ1 Gene PreventionGenetics, part of Exact Sciences United States | 1 | 1 |
|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
Nephrolithiasis panel. 35-gene NGS panel. Genologica Medica Spain | 60 | 35 |
|
Bartter syndrome panel. 9-gene NGS panel. Genologica Medica Spain | 13 | 9 |
|
Bartter/Gitelman Syndromes (NGS Panel and Copy Number Analysis) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 6 | 8 |
|
Asper Biogene Asper Biogene LLC Estonia | 35 | 24 |
|
Bartter syndrome: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 7 | 6 |
|
Fulgent Genetics United States | 39 | 27 |
|
BARTTER SYNDROME, ANTENATAL, TYPE 2 Laboratorio de Genetica Clinica SL Spain | 1 | 1 |
|
Bioarray Spain | 1 | 1 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.